Athersys reports positive results of MultiStem trial

MultiStem, a stem cell treatment from Athersys, improved heart function and was well-tolerated by heart attack patients given three different dosages. The early-stage trial involved the use of a catheter to deliver the stem cells directly to damaged parts of the heart two to five days after the patient's attack.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC